Improving cancer treatment and care for patients in Central and Western New York
Official title: University of Rochester Wilmot Cancer Institute Support Grant
Funded at University of Rochester · NIH-11014524 · Data updated 2026-11-12
The Wilmot Cancer Institute is working on new ways to improve cancer treatment and support, especially for older adults and underserved communities, so that patients can receive the best care and innovative therapies designed just for them.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $2,075,744 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014524 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals diagnosed with cancer, particularly those from aging populations or underserved communities in Central and Western New York.
✕Less likely to help
Patients with non-cancerous conditions or those outside the catchment area may not receive benefits from this research.
What this research studies
The Wilmot Cancer Institute at the University of Rochester aims to enhance cancer treatment and care through innovative medicine and research. This initiative focuses on addressing the unique challenges faced by a population with a high incidence of cancer, particularly among aging individuals and underserved communities. The research encompasses various aspects of cancer control, including genetics, metabolism, and the cancer microenvironment, to develop effective strategies for prevention and supportive care. Patients can expect to benefit from cutting-edge therapies and comprehensive support tailored to their specific needs.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment protocols and better patient outcomes for those affected by cancer.
How similar studies have gone: Previous research in cancer control and supportive care has shown significant success, indicating that this approach is both tested and promising.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Friedberg, Jonathan W — University of Rochester
- Study coordinator: Friedberg, Jonathan W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.